NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Drug Screening


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
'Tis the Season...To Check Your Prescription Drug Benefit
2009 NOV 23 ... of thousands of older Americans counting on federal assistance with their prescription drug costs in 2010 need to make sure they still qualify for this important benefit. ... forms for these programs are provided as part of BenefitsCheckUp's interactive screening process. Since 2001, more than 2.3 million people have used the service, identifying ...
Subject: National Council on Aging
Price: $3.00
*
Millennium Laboratories Announces Five Drug Screening Tests to Help Pain Physicians with Therapeutic Patient Care
2009 NOV 23 ... chromatography/tandem mass spectrometry (LC-MS/MS). In addition, the company now offers drug screening tests for heroin metabolite 6-Monoacetylmorphine, alcohol biomarkers ethyl glucuronide ...
Subject: Millennium Laboratories
Price: $3.00
*
National Cancer Institute reports research in breast cancer screening
2009 NOV 23 ... data sources: (1) 2001 California Health Interview Survey (CHIS) data, (2) 2001 Food and Drug Administration (FDA) certified mammography facility data, (3) 2003 LA Transit Authority ... and colleagues published their study in Cancer Causes & Control (Access to mammography screening in a large urban population: a multi-level analysis. Cancer Causes & Control, ...
Subject: Breast Cancer Screening
Price: $3.00
*
New angiogenesis research from Harvard University, Medical Department discussed
2009 NOV 23 ... to pathological retinopathy, and are also in vivo tools for anti-angiogenic drug screening in cancer and ophthalmic research," investigators in the United States report. ...
Subject: Angiogenesis
Price: $3.00
*
New data from S. Valway et al illuminate research in virology
2009 NOV 23 ... = 15.04; 95% confidence interval [CI] = 1.92, 117.53; P = .01), history of injection drug use (IDU; OR = 2.69; 95% CI = 1.19, 6.12; P = .02), and history of an STI (OR = 2.47; ... The researchers concluded: "Our results suggest a need for hepatitis C screening and STI risk-reduction interventions in this population. (Am J Public Health. 2009;99: ...
Subject: Virology
Price: $3.00
*
New High Shear Microplate Enables Cellular Pathology Studies with BioFlux(TM) Platform
2009 NOV 23 ... an effective tool in thrombosis and platelet studies, cardiovascular and immunological drug screening and cell/bacteria adhesion research. The BioFlux 200 and 1000 platforms ...
Subject: Fluxion Biosciences
Price: $3.00
*
New hyperparathyroidism study findings have been reported from Pennsylvania State University, Medical Department
2009 NOV 23 ... unilateral exploration (no recommendation). There may be a role for calcimimetic drug therapy as an alternate, nonsurgical means of controlling lithium-associated ... hyperparathyroidism (grade C recommendation). Evidence-based recommendations support screening of patients on chronic lithium therapy for hypercalcemia. Appropriate surgical therapy ...
Subject: Hyperparathyroidism
Price: $3.00
*
New Start-up Enavail Applies Proprietary Particle Engineering Technologies To Increase Drug Solubility, Stability and Bioavailability
2009 NOV 23 ... the spectrum. Enavail offers custom, economical solutions to partners from initial drug screening (even microgram quantities) through to cGMP manufacturing of materials for clinical ...
Subject: Enavail
Price: $3.00
*
New tuberculosis study findings have been reported by M. Nomoto and colleagues
2009 NOV 23 ... shuttle vector pYT923 (previously constructed in our laboratory) to obtain three drug resistant genes (amp-, hyg- and km-resistant gene) and cloning sites in the km resistant ... growth of M. tuberculosis in phagocytic cells; this system may be useful as a screening tool for M. tuberculosis genes." Nomoto and colleagues published their ...
Subject: Tuberculosis
Price: $3.00
*
Pipeline Insight: Colorectal Cancer - Growing Trend towards Personalized Medicine
2009 NOV 23 ... Segmentation and analysis of the current CRC pipeline by developmental phase, drug class and company Insight and analysis of market potential including ... Rise of CRC in the migrant population Symptoms Screening and diagnosis Fecal occult blood test is the most commonly used screening ...
Subject: Research and Markets
Price: $3.00
*
Recent findings from University of Hull, Post Graduate Medical Institute highlight research in breast cancer therapy
2009 NOV 23 ... Kingdom, Hull, Breast Cancer Therapy, Biotechnology, Breast Cancer, Breast Carcinoma, Drug Development, Experimental Design, Neoplasia, Oncology, Pharmaceuticals, Proteomics, ... with the radioresistant phenotype. To identify these biomarkers, complementary proteomic screening approaches were exploited encompassing two-dimensional gel electrophoresis in ...
Subject: Breast Cancer Therapy
Price: $3.00
*
Reports from Philipps University, Institute of Medical Microbiology and Hygiene describe recent advances in surgery
2009 NOV 23 ... Antimicrobial Resistance, Cardiology, Clinical Microbiology, Diagnosis, Diagnostics, Drug Resistance, Enzymes, Heart Surgery, Infectious Diseases, Polymerase, Therapy, Treatment. ... A new study, 'Cost-effectiveness of rapid MRSA screening in surgical patients,' is now available. "This study investigates the effectiveness of ...
Subject: Surgery
View Free
Daily News
Article
Reports summarize strep infection study results from L. Miguet and co-researchers
2009 NOV 23 ... City:Grenoble, Country:France, Antibacterial, Antibiotic, Antimicrobial Resistance, Drug Resistance, Drugs, Medicinal Chemistry, Penicillin G Potassium, Pharmaceuticals, Strep ... chemical scaffold so as to circumvent the resistance problems, a hierarchical virtual screening procedure was performed on the NCI database containing approximately 260000 compounds. ...
Subject: Strep Infection
Price: $3.00
*
Research from C.K. Hahn and colleagues provide new insights into proteomics
2009 NOV 23 ... Syk as a target in AML. Genetic and pharmacological inactivation of Syk with a drug in clinical trial for other indications promoted differentiation of AML cells and ... "Cell-based screening can facilitate the rapid identification of compounds inducing complex cellular ...
Subject: Proteomics
Price: $3.00
*
Research from D. Platt et al has provided new information about paralysis
2009 NOV 23 ... for the study of mexiletine in nondystrophic myotonias. The class IC antiarrhythmia drug flecainide has been shown to depress ventricular ectopy and improve exercise capacity in ... continues to grow with the advent of exon hierarchy analysis strategies for genetic screening and better understanding and recognition of disease phenotypes," scientists in the ...
Subject: Paralysis
Price: $3.00
*
Research in the area of physical medicine reported from A.L. Harrington and colleagues
2009 NOV 24 ... a primary care physician. Participant report of screening for alcohol, nonprescription drug use, and safety with relationships at home ranged from 26.6% to 37.5% compared with ...
Subject: Physical Medicine
Price: $3.00
*
Safeway Raises $18.2 Million for Breast Cancer Research
2009 NOV 23 ... a consortium comprised of researchers from the National Cancer Institute, the Food and Drug Administration, the National Institutes of Health, and a large number of partners from ... cancer centers in North America dedicated to breast cancer research, diagnosis and screening. "We are grateful to our customers who, in a challenging economic climate, ...
Subject: Safeway Inc.
Price: $3.00
*
Scientists at University of Colorado publish research in arthritis
2009 NOV 23 ... 9JR, England. Keywords: State:CO, Country:United States, Abatacept, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Anticancer Therapy, Arthritis, ... greater. ''Washout'' patients discontinued anti-TNF therapy 2 months or longer pre-screening; ''direct-switch'' patients began abatacept (similar to 10 mg/kg) at their next ...
Subject: Arthritis
Price: $3.00
*
Studies from C.E. Meacham and co-researchers update current data on lymphoma
2009 NOV 23 ... vivo. Validation experiments confirmed that these proteins represent bona fide lymphoma drug targets," wrote C.E. Meacham and colleagues. The researchers concluded: ... United States report. "Here, we report the adaptation of loss-of-function screening to mouse models of cancer. Specifically, we have been able to introduce a library of ...
Subject: Lymphoma
Price: $3.00
*
Uppsala University publishes research in pharmacokinetics
2009 NOV 23 ... According to a study from Uppsala, Sweden, "Generally, gastric emptying of a drug to the small intestine is controlled by gastric motor activity and is the main factor ... lag-time in gastric emptying. Based on the literature, a two hour time frame for screening the in vitro dissolution profile of a controlled release product in ethanol ...
Subject: Pharmacokinetics
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login